Evoke Pharma, Inc. (EVOK) NASDAQ

4.80

-0.0222(-0.46%)

Updated at September 30 11:26AM

Currency In USD

Valuation

Market Cap8.42M
Enterprise Value-15,690
P/E Ratio-2.28
PEG Ratio-0.23
Price/Sales Ratio0.58
Price/Book Ratio2.8
Enterprise/Revenue0.04
Enterprise/EBITDA-0.11

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.42
Operating Margin-0.42

Management Effectiveness

Return On Assets-0.34
Return On Equity-0.99

Income Statement

Revenue10.25M
Revenue/Share5.01
Gross Profit9.89M
EBITDA-4.85M
Net Income-5.35M
Diluted EPS-2.81

Balance Sheet

Total Cash12.06M
Total Cash/Share4.72
Total Debt5.13M
Total Debt/Equity1.17
Current Ratio1.37
Book Value Per Share1.71

Price History

52-Week Change0.79
52-Week High12.32
52-Week Low1.94
Moving Average 50 Days5.1
Moving Average 200 Days4.08

Statistics

Average Volume2.47M
Shares Outstanding1.56M
% Held by Institutions6.09

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateAugust 01, 2024